NO20004491D0 - Blanding - Google Patents
BlandingInfo
- Publication number
- NO20004491D0 NO20004491D0 NO20004491A NO20004491A NO20004491D0 NO 20004491 D0 NO20004491 D0 NO 20004491D0 NO 20004491 A NO20004491 A NO 20004491A NO 20004491 A NO20004491 A NO 20004491A NO 20004491 D0 NO20004491 D0 NO 20004491D0
- Authority
- NO
- Norway
- Prior art keywords
- mixture
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Confectionery (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7748098P | 1998-03-11 | 1998-03-11 | |
| US7752798P | 1998-03-11 | 1998-03-11 | |
| GBGB9805192.3A GB9805192D0 (en) | 1998-03-11 | 1998-03-11 | Composition |
| PCT/EP1999/001557 WO1999045924A1 (en) | 1998-03-11 | 1999-03-05 | Composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004491D0 true NO20004491D0 (no) | 2000-09-08 |
| NO20004491L NO20004491L (no) | 2000-09-08 |
Family
ID=27269240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004491A NO20004491L (no) | 1998-03-11 | 2000-09-08 | Blanding |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6451343B1 (no) |
| EP (1) | EP1061918A1 (no) |
| JP (1) | JP2002506031A (no) |
| KR (1) | KR20010034588A (no) |
| CN (1) | CN1292696A (no) |
| AR (1) | AR018147A1 (no) |
| AU (1) | AU748396C (no) |
| CA (1) | CA2323177A1 (no) |
| CO (1) | CO5080740A1 (no) |
| HU (1) | HUP0101043A3 (no) |
| IL (1) | IL138192A0 (no) |
| NO (1) | NO20004491L (no) |
| NZ (1) | NZ505807A (no) |
| PL (1) | PL342600A1 (no) |
| TR (1) | TR200002626T2 (no) |
| WO (1) | WO1999045924A1 (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2813651B1 (fr) | 2000-09-05 | 2004-06-11 | Valeo | Appareil d'accouplement hydrocinetique, notamment pour vehicule automobile |
| CA2470636A1 (en) * | 2001-12-20 | 2003-07-03 | Pharmacia Corporation | Zero-order sustained released dosage forms and method of making the same |
| AR040683A1 (es) * | 2002-07-25 | 2005-04-13 | Pharmacia Corp | Composicion de tabletas de liberacion sostenida que comprende un agonista de los receptores de la dopamina |
| PA8578501A1 (es) * | 2002-07-25 | 2005-02-04 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
| US20050226926A1 (en) * | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
| US20070196481A1 (en) * | 2002-07-25 | 2007-08-23 | Amidon Gregory E | Sustained-release tablet composition |
| UA93608C2 (ru) | 2004-08-13 | 2011-02-25 | Берингер Ингельхайм Интернациональ Гмбх | композициЯ таблетки пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, СПОСОБ EE ИЗГОТОВЛЕНИЯ И EE ПРИМЕНЕНИЕ |
| CN101022788B (zh) * | 2004-08-13 | 2010-11-10 | 贝林格尔·英格海姆国际有限公司 | 包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途 |
| WO2007090883A1 (en) * | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Extended release formulation |
| EP1988875A2 (en) * | 2006-02-10 | 2008-11-12 | Boehringer Ingelheim International GmbH | Modified release formulation |
| US20080014257A1 (en) * | 2006-07-14 | 2008-01-17 | Par Pharmaceutical, Inc. | Oral dosage forms |
| US9290759B2 (en) * | 2010-08-25 | 2016-03-22 | The Trustees Of Columbia University In The City Of New York | Optimized miRNA constructs |
| PL3325444T3 (pl) | 2015-07-20 | 2021-12-06 | Acadia Pharmaceuticals Inc. | Sposoby wytwarzania N-(4-fluorobenzylo)-N-(1-metylopiperydyn-4-ylo)-N'-(4-(2-metylopropyloksy)fenylometylo)karbamidu oraz jego soli winianowej i postaci polimorficznej C |
| WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
| US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
| EP3558311A1 (en) | 2016-12-20 | 2019-10-30 | Acadia Pharmaceuticals Inc. | Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis |
| WO2018200977A1 (en) | 2017-04-28 | 2018-11-01 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
| WO2019046167A1 (en) * | 2017-08-30 | 2019-03-07 | Acadia Pharmaceuticals Inc. | PIMAVANSERIN FORMULATIONS |
| US11648242B2 (en) * | 2019-12-12 | 2023-05-16 | Aurobindo Pharma Ltd | Pharmaceutical composition comprising pimavanserin, process of preparation and use thereof |
| WO2026018155A1 (en) | 2024-07-16 | 2026-01-22 | Syremis Therapeutics Ltd. | Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists |
| WO2026018154A1 (en) | 2024-07-16 | 2026-01-22 | Syremis Therapeutics Ltd. | Combinations of sabcomeline with non-cns penetrant muscarinic antagonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU207444B (en) | 1990-07-12 | 1993-04-28 | Biorex Kutato Fejlesztoe Kft | Method for producing therapeutical preparation suitable for treating alzheimer-disease |
| US5433951A (en) * | 1993-10-13 | 1995-07-18 | Bristol-Myers Squibb Company | Sustained release formulation containing captopril and method |
| GB9421472D0 (en) | 1994-10-25 | 1994-12-07 | Smithkline Beecham Plc | Novel methods |
| AR004178A1 (es) | 1995-07-29 | 1998-11-04 | Smithkline Beecham Plc | Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma. |
| GB9619074D0 (en) | 1996-09-12 | 1996-10-23 | Smithkline Beecham Plc | Composition |
-
1999
- 1999-03-05 JP JP2000535339A patent/JP2002506031A/ja not_active Withdrawn
- 1999-03-05 US US09/623,213 patent/US6451343B1/en not_active Expired - Fee Related
- 1999-03-05 AU AU30332/99A patent/AU748396C/en not_active Ceased
- 1999-03-05 WO PCT/EP1999/001557 patent/WO1999045924A1/en not_active Ceased
- 1999-03-05 KR KR1020007010054A patent/KR20010034588A/ko not_active Withdrawn
- 1999-03-05 NZ NZ505807A patent/NZ505807A/xx unknown
- 1999-03-05 EP EP99911765A patent/EP1061918A1/en not_active Withdrawn
- 1999-03-05 CN CN998038202A patent/CN1292696A/zh active Pending
- 1999-03-05 TR TR2000/02626T patent/TR200002626T2/xx unknown
- 1999-03-05 PL PL99342600A patent/PL342600A1/xx unknown
- 1999-03-05 IL IL13819299A patent/IL138192A0/xx unknown
- 1999-03-05 CA CA002323177A patent/CA2323177A1/en not_active Abandoned
- 1999-03-05 HU HU0101043A patent/HUP0101043A3/hu unknown
- 1999-03-09 AR ARP990100991A patent/AR018147A1/es unknown
- 1999-03-11 CO CO99015121A patent/CO5080740A1/es unknown
-
2000
- 2000-09-08 NO NO20004491A patent/NO20004491L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR018147A1 (es) | 2001-10-31 |
| AU748396B2 (en) | 2002-06-06 |
| NZ505807A (en) | 2003-01-31 |
| WO1999045924A1 (en) | 1999-09-16 |
| IL138192A0 (en) | 2001-11-25 |
| CA2323177A1 (en) | 1999-09-16 |
| AU3033299A (en) | 1999-09-27 |
| TR200002626T2 (tr) | 2001-03-21 |
| AU748396C (en) | 2003-01-23 |
| HUP0101043A3 (en) | 2002-02-28 |
| HUP0101043A2 (hu) | 2001-12-28 |
| PL342600A1 (en) | 2001-06-18 |
| US6451343B1 (en) | 2002-09-17 |
| KR20010034588A (ko) | 2001-04-25 |
| EP1061918A1 (en) | 2000-12-27 |
| NO20004491L (no) | 2000-09-08 |
| CO5080740A1 (es) | 2001-09-25 |
| CN1292696A (zh) | 2001-04-25 |
| JP2002506031A (ja) | 2002-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE446389T1 (de) | Enzymgemisch | |
| NO951704L (no) | Vann-avstötende blanding | |
| DK0900021T3 (da) | Fungicid blanding | |
| NO20002515L (no) | Mineralullblanding | |
| NO20001014D0 (no) | Dermatologisk blanding | |
| NO994003L (no) | Farmasoytisk blanding | |
| NO20000028L (no) | Mineralull-blanding | |
| ID23234A (id) | Turunan-turunan benzosulfona | |
| NO985864D0 (no) | Antiviral blanding | |
| NO20004491D0 (no) | Blanding | |
| DE59906237D1 (de) | Pigmentmischung | |
| ID23287A (id) | Trisiklik tersubstitusi | |
| NO20000030D0 (no) | Mineralullblanding | |
| DE69808366D1 (de) | Dimmer | |
| ID23219A (id) | Trisiklik tersubstitusi | |
| DK0986304T3 (da) | Fungicid blanding | |
| NO20020710D0 (no) | Varmelagrende blanding | |
| DK1139758T3 (da) | Fungicid blanding | |
| NO20000107D0 (no) | Ny blanding | |
| FI974212A7 (fi) | Eristin | |
| DE69923371D1 (de) | Koaxialkabel | |
| DE59911610D1 (de) | Substituierte benzoylcyclohexandione | |
| NO20003639D0 (no) | Oral oljeabsorberende blanding | |
| NO20003834D0 (no) | Blanding | |
| DE59810662D1 (de) | Koaxialverbinder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |